Catalyzing Research
First Lupus Nephritis Drug Approved
In December of 2020, lupus research attained another major milestone-one which stemmed from a critical...
Search Results
You searched for: lupus nephritis
Results found: 173
Two New Drugs Receive FDA Approval
May 1, 2021
“This is a historic moment in lupus with two new drug approvals for lupus nephritis just over...
Accelerating Medicines Partnership Completes Key Phase
September 24, 2019
The Accelerating Medicines Partnership (AMP) RA/Lupus Program, a joint effort involving the National Institutes of Health (NIH),...
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio,...
Results of Two Voclosporin Trials Presented at Key Medical Meeting
October 22, 2020
Aurinia Pharmaceuticals announced that data taken from a combined analysis of two trials, AURA-LV and AURORA underscored...
New TIL Grantees Offer Novel Approaches
Sept. 7, 2017. Grantees of our Target Identification in Lupus (TIL) program are remarkable scientific investigators whose ingenuity and...
Data Shows Voclosporin Preserves Kidney Function for Three Years
July 19,2023
The LRA is pleased to share news announced by Aurinia Pharmaceuticals of published results showing that the lupus...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...
Advancing Research Exponentially
August 14, 2018
Advancing Research Exponentially
An Update on AMP
by Jill Buyon, MD
Lupus nephritis (LN), one of the dreaded complications of...
Living in a Disadvantaged Neighborhood Lowers Follow-up Care
March 4, 2020
A new study showed that living in a disadvantaged neighborhood predicts poor retention (follow-up) care for people...
KZR-616 Shows Promise According to Results Reported at EULAR
Kezar Life Sciences announced positive results from the MISSION Phase 1 study testing the investigational KZR-616 as a treatment...
LRA Congratulates Aurinia on Published Results with FDA-Approved Lupkynis™
May 10, 2021
The highly prestigious medical journal The Lancet published the results of Aurinia’s Phase 3 AURORA 1 study testing...